Use of efrapeptin oligopeptides for inhibition of angiogenesis

摘要

The present invention provides a method for the treatment of angiogenesis-related diseases. The treatment comprises administering to a human or animal suffering from an angiogenesis-related disease therapeutically active dosages of one or more efrapeptin oligopeptides. Efrapeptin oligopeptides are shown to inhibit angiogenesis-related diseases such as cancer by inhibiting proliferation and migration of endothelial cell. <IMAGE>